with a focus on therapeutic drug monitoring

We produce, market and sell diagnostic products with innovative vision

Our products

Phosphatidylethanol (PEth)

Phosphatidylethanol (PEth) in the blood is a biomarker for alcohol consumption and is in the body an unnatural phospholipid that can only be formed in presence of alcohol, which theoretically provides 100% diagnostic specificity for alcohol.

Tamoxifen

Tamoxifen is widely prescribed for women with breast cancer and a 5- to 10-year treatment is recommended to prevent recurrence of the cancer. Tamoxifen is a prodrug, it must be metabolized in the body to be active; the primary active metabolites are z-endoxifen and 4-hydroxy tamoxifen. redhot diagnostics has developed a system for Therapeutic Dose Monitoring to help these women to get a correct dose of tamoxifen.

Methylmalonic Acid (MMA)

Elevated levels of Methylmalonic acid (MMA) are an indication of vitamin B12 deficiency. redhot has developed a new method for determination of methylmalonic acid that circumvents the problem with background from MMA in blank blood, using the HILIC separation technique. It is a very robust and sensitive method. The LC-MS/MS application is intended for the quantitative determination of Methylmalonic acid (MMA) in serum/plasma (whole blood), and is available as a prototype.

rhelise™ kit

redhot diagnostics has developed a new blood sampling kit, rhelise ™ kit. The kit is intended to be used by a layperson to collect capillary whole blood for analysis of biomarkers and drug metabolites. The capillary takes typically 20 - 70 µL of blood. The kit is developed for PEth, Tamoxifen and Methylmalonic Acid (B-vitamin deficiency)

Our company

redhot diagnostics AB is a company that offers state-of-the art diagnostic products to research and routine laboratories at hospitals. Using our patent-pending rhelise™ kit, we are enabling diagnostic testing and therapeutic drug monitoring of patients in their home environment.